AN2 Therapeutics is a startup based in the United States, 2 tracked investors.
Based in the United States, AN2 Therapeutics is a startup. Brouky records 2 investors associated with the company.
AN2 Therapeutics develops novel boron-based small molecule therapies targeting rare, chronic, and serious infectious diseases, hematology, and oncology conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.